Updated Date: Fri, 17 Feb 2023 00:00:00 EST

Updated Date: Fri, 17 Feb 2023 00:00:00 EST

Updated Date: Fri, 17 Feb 2023 00:00:00 EST

Updated Date: Fri, 17 Feb 2023 00:00:00 EST

Updated Date: Fri, 17 Feb 2023 00:00:00 EST

Treatment is an BTK inhibitor and has demonstrated a sound safety and tolerability profile

Africa-based trials for blood test which detects risk of disease progression are due to begin

Phase 1/2 research shows that treatment could be very effective against Fabry disease

Next phase of Newel Health’s digital therapeutics solution for Parkinson’s disease gains vital grant

Research will analyse how Huawei’s wearable technology detects atrial fibrillation in post-stroke patients